Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Prezinton injection

Dexa Medica

Ingredients in every ml

Ondansetron 2 mg

Each package contains

2 ampoules of 4 ml

Dosage form

injection

Dosage formInjection

Flavour

None

W.H.O. classification

A04A
A04A

A.T.C. Level 1

Anatomical Main group

A - Alimentary tract and metabolism
A04A

A.T.C. Level 2

Therapeutic subgroup

A04 - Antiemetics and Antinauseants
A04A

A.T.C. Level 3

Pharmacological subgroup

A04A - Antiemetics and Antinauseants

Available in

Myanmar

Warnings

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

SAFE IF PRESCRIBEDThis item is safe for use while operating heavy machinery.

Pregnancy

NOT RECOMMENDEDThis item is not safe for use during pregnancy.

Lactation

NOT RECOMMENDEDThis item is not safe for use during lactation.

Indication

Treatment and prevention of nausea and vomiting associated with chemotherapy, radiotherapy and surgery.

Dosage

18 TO 65 YEARS OLD
The treatment of postoperative nausea and vomiting:
A single 4 mg dose by intramuscular or slow intravenous injection.

Prevention and therapy of chemotherapy induced nausea and vomiting
- Highly emetogenic chemotherapy, e.g., cisplatin.
Initially, ondansetron 8 mg by slow intravenous injection or by intravenous infusion over a period of at least 15 minutes immediately before treatment, followed by a continuous intravenous infusion of 1 mg per hour for up to 24 hours, or by a further two doses of 8 mg by slow intravenous injection or by intravenous infusion over at least 15 minutes four hours apart. Or may be followed with ondansetron 8 mg orally twice daily for up to 5 days.
- Less emetogenic chemotherapy, e.g. cyclophosphamide.
Ondansetron 8 mg may be given as a slow intravenous injection or by intravenous infusion over a period of at least 15 minutes immediately before treatment, followed by 8 mg orally twice daily for up to 5 days.

4 TO 18 YEARS OLD
Prevention and therapy of chemotherapy induced nausea and vomiting.
5 mg/m2 intravenously over 15 minutes immediately before chemotherapy, followed by 4 mg orally twice daily for 5 days.

65 YEARS OLD AND ABOVE
Ondansetron is well tolerated in patients over 65 years without dosage adjustment, frequency and method of administration.

PATIENT WITH RENAL IMPAIRMENT
Do not require daily dose adjustment, frequency or drug administration.

PATIENTS WITH HEPATIC IMPAIRMENT
The total daily dose of 8 mg ondansetron should not be exceeded.